RecruitingNot applicableMale onlyEN originalProstate cancer

E-Mergir: A Digital Psychosexual Intervention for the Promotion of Mental and Sexual Health of Prostate Cancer Survivors

⚠️

This is not medical advice. AI-assisted translation — inaccuracies may occur. Always verify the original and consult your oncologist before taking any steps.

About the trial

Prostate cancer (PCa) survivors frequently experience enduring psychosexual challenges following treatment, including sexual dysfunction, emotional distress, and reduced quality of life. Despite these difficulties, access to tailored support remains limited, highlighting the need for scalable and accessible alternatives such as digital interventions. This study presents the protocol for a randomized controlled trial (RCT) evaluating the effectiveness of E-Mergir, a digital psychosexual intervention developed for PCa survivors. Grounded in cognitive behavioral therapy (CBT) and mindfulness strategies, the intervention aims to enhance both sexual and mental well-being. The trial employs a wait-list control design with randomized allocation. Participants will complete assessments at baseline, post-intervention, and follow-up, using validated measures related to sexual outcomes (sexual satisfaction, pleasure, function, distress, and beliefs) and mental health outcomes (quality of life, anxiety, depression, mindfulness, relationship satisfaction, and automatic thoughts). The study aims to determine whether E-Mergir is an effective digital intervention for improving psychosexual outcomes in PCa survivors, compared to a wait-list control group. It also aims to examine treatment predictors to illustrate the mechanisms through which improvements in mental and sexual health are achieved. If effective, E-Mergir could address a critical gap in supportive care for PCa survivors and serve as a model for culturally tailored digital psychosexual interventions globally.

Original English text from ClinicalTrials.gov

Who can (and can't) join

✓ Qualifies

  • Osoby, które miały raka prostaty
  • Wiek 18 lat lub więcej
  • Zdolność do wyrażenia świadomej zgody na uczestnictwo
  • Regularne korzystanie ze smartfona i dostęp do internetu

✗ Disqualifies

  • Inny rozpoznany nowotwór w ciągu ostatnich 5 lat
  • Poważne uszkodzenie układu nerwowego lub inne poważne zaburzenia psychiczne (depresja, zaburzenia lękowe, psychoza)
  • Inne niekontrolowane lub niestabilne choroby
  • Poważne problemy ze słuchem lub wzrokiem
  • Aktualnie leczenie psychologiczne lub terapia problemów seksualnych
  • Uczestnictwo w innych badaniach klinicznych

Simplified criteria — AI translation

Trial details

Minimum age
18 Years
Last updated (source)
August 10, 2026
Sex
Male only

Therapies / drugs in trial

Locations (1)

Faculdade de Psicologia e de Ciências da Educação da Universidade do Porto

Porto, Portugal

Trial contact

Ana Luísa Quinta Gomes, PhD

Sonia Pieramico, MSc

Contact information from ClinicalTrials.gov. Contact in English.

Share this trial

Data from ClinicalTrials.gov. AI-assisted translation, last sync: 8/11/2026.

You can help another person

We fund the Radar, this site, and the development of our Grosz dla Życia fundraising platform from donations and our own resources. Every contribution, even a small one, really helps.